» Authors » Jean-Luc Pasquie

Jean-Luc Pasquie

Explore the profile of Jean-Luc Pasquie including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 82
Citations 1545
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Souilla L, Werner O, Huguet H, Gavotto A, Vincenti M, Pasquie J, et al.
JAMA Netw Open . 2025 Feb; 8(2):e2461795. PMID: 39998828
Importance: Historical restrictions on children with inherited cardiac arrhythmia or cardiomyopathy have been implemented to mitigate the potential risk of sudden death, but these limitations can be detrimental to overall...
2.
Brobst M, Chapet N, Benchalkha D, Bourgeois E, Herman F, Molinari N, et al.
Arch Cardiovasc Dis . 2024 Dec; 118(2):85-92. PMID: 39732563
Background: Recommended treatment after acute coronary syndrome (ACS) involves high-intensity statin therapy to achieve the low-density lipoprotein (LDL-C) target of<1.4mmol/L (European guidelines), but many patients discontinue statins because of real...
3.
Echivard M, Sellal J, Ziliox C, Marijon E, Bordachar P, Ploux S, et al.
Eur Heart J . 2024 Sep; 45(41):4428-4442. PMID: 39299922
Background And Aims: Prophylactic implantable cardioverter-defibrillators (ICDs) are not recommended until left ventricular ejection fraction (LVEF) has been reassessed 40 to 90 days after an acute myocardial infarction. In the...
4.
Cardelli L, Laumont T, Beghian J, Achahli Y, Cardoso M, Bacle M, et al.
J Clin Med . 2024 Sep; 13(17). PMID: 39274366
: Most data on radiofrequency (RF) effects come from ex vivo or in vitro studies that quantify lesions using width and/or depth, while electrophysiologists use manufacturers' indirect indices. The objective...
5.
Roubille F, Labarre J, Georger F, Galinier M, Herman F, Berdague P, et al.
J Am Heart Assoc . 2024 Jul; 13(15):e032931. PMID: 39023055
Background: The PRADO-IC (Programme de Retour à Domicile après une Insuffisance Cardiaque) is a transition care program designed to improve the coordination of care between hospital and home that was...
6.
Souilla L, Guillaumont S, Auer A, Metzler G, Requirand A, Vincenti M, et al.
BMC Sports Sci Med Rehabil . 2024 Jul; 16(1):152. PMID: 38997778
Background: To assess the feasibility, acceptability, safety, and short-term benefits of a tailored cardiac rehabilitation program for children and adolescents with long QT syndrome (LQTS). Methods: Eight participants, aged between...
7.
Deliniere A, Bessiere F, Placide L, Pasquie J, Haddad C, Tirel S, et al.
Arch Cardiovasc Dis . 2024 May; 117(5):313-320. PMID: 38704288
Background: In patients with congenital long QT syndrome (LQTS), the risk of ventricular arrhythmia is correlated with the duration of the corrected QT interval and the changes in the ST-T...
8.
Magaldi M, Nogue E, Molinari N, De Luca N, Dupuy A, Leclercq F, et al.
J Clin Med . 2024 Apr; 13(7). PMID: 38610783
: Acute heart failure (AHF) represents a leading cause of unscheduled hospital stays, frequent rehospitalisations, and mortality worldwide. The aim of our study was to develop a bedside prognostic tool,...
9.
Sleiman Y, Reiken S, Charrabi A, Jaffre F, Sittenfeld L, Pasquie J, et al.
Stem Cell Res Ther . 2023 Sep; 14(1):266. PMID: 37740238
Background: Polymorphic ventricular tachycardia (PMVT) is a rare genetic disease associated with structurally normal hearts which in 8% of cases can lead to sudden cardiac death, typically exercise-induced. We previously...
10.
Goual L, Bounasri E, Vincenti M, Amedro P, Desprat R, Bernex F, et al.
Stem Cell Res . 2023 Sep; 72:103192. PMID: 37660555
Type 2 Long QT Syndrome (LQT2) is a rare genetic heart rhythm disorder causing life-threatening arrhythmias. We derived induced pluripotent stem cell (iPSC) lines from two patients with LQT2, aged...